About this document
Tirzepatide by Fabian is a document available to read on EtoBox.
This review article discusses the effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on cardiometabolic parameters in individuals with obesity and type 2 diabetes. Clinical trial evidence indicates that tirzepatide treatment leads to significant improvements in glycaemic control, body weight reduction, and various cardiometabolic markers, including blood pressure and lipid profiles. The findings suggest a promising outlook for tirzepatide in reducing cardiovascular risks and improving overall me
- Author
- Fabian
- Language
- EN